Search research articles
Contact Us
Filters
Showing results (141-150 of 216) with videos related to
Page
of 22
Sort By:
Nature Communications
|
August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Kevin Litchfield, James L Reading, Emilia L Lim, et al.
Cell Research
|
July 15, 2025
Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression
Wei Liu, Tao Shi, Chun Lu, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2026
Expert opinion on burning questions in cancer myeloid cell biology
Jennifer L Guerriero, Miriam Merad, Florent Ginhoux, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Plos One
|
December 19, 2013
Enhanced responses to tumor immunization following total body irradiation are time-dependent
Adi Diab, Robert R Jenq, Gabrielle A Rizzuto, et al.
The New England Journal of Medicine
|
November 20, 2014
Genetic basis for clinical response to CTLA-4 blockade in melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, et al.
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
Dmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2021
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer
Jia Luo, Victoria L Martucci, Zoe Quandt, et al.
The Journal of Biological Chemistry
|
May 5, 2017
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF<sup>V600E</sup> in human cancers
Liang Zhao, Jun Fan, Siyuan Xia, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 216) with videos related to
Sort By:
Page
of 22
Nature Communications
|
August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Kevin Litchfield, James L Reading, Emilia L Lim, et al.
Cell Research
|
July 15, 2025
Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression
Wei Liu, Tao Shi, Chun Lu, et al.
Journal for Immunotherapy of Cancer
|
June 3, 2026
Expert opinion on burning questions in cancer myeloid cell biology
Jennifer L Guerriero, Miriam Merad, Florent Ginhoux, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Plos One
|
December 19, 2013
Enhanced responses to tumor immunization following total body irradiation are time-dependent
Adi Diab, Robert R Jenq, Gabrielle A Rizzuto, et al.
The New England Journal of Medicine
|
November 20, 2014
Genetic basis for clinical response to CTLA-4 blockade in melanoma
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, et al.
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
Dmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2021
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer
Jia Luo, Victoria L Martucci, Zoe Quandt, et al.
The Journal of Biological Chemistry
|
May 5, 2017
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF<sup>V600E</sup> in human cancers
Liang Zhao, Jun Fan, Siyuan Xia, et al.
Page
of 22